United States Crohn?s Disease Drug Market Report 2018

March 2018 | 96 pages | ID: U27F8898825QEN
QYResearch

Abstracts

In this report, the United States Crohn?s Disease Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Crohn?s Disease Drug in these regions, from 2013 to 2025 (forecast).

United States Crohn?s Disease Drug market competition by top manufacturers/players, with Crohn?s Disease Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AbbVie
• Janssen Biotech
• UCB
• Amgen
• Tillotts Pharma
• Takeda Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Aminosalicylates (5-ASA)
• Corticosteroids
• Immunomodulators
• Antibiotics

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Achieving Remission (The Absence Of Symptoms)
• Maintaining Remission (Prevention Of Flare-Ups)
• Pediatric Crohn'S Disease

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Crohn?s Disease Drug Market Report 2018

1 CROHN?S DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Crohn?s Disease Drug
1.2 Classification of Crohn?s Disease Drug by Product Category
  1.2.1 United States Crohn?s Disease Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Crohn?s Disease Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Aminosalicylates (5-ASA)
  1.2.4 Corticosteroids
  1.2.5 Immunomodulators
  1.2.6 Antibiotics
1.3 United States Crohn?s Disease Drug Market by Application/End Users
  1.3.1 United States Crohn?s Disease Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Achieving Remission (The Absence Of Symptoms)
  1.3.3 Maintaining Remission (Prevention Of Flare-Ups)
  1.3.4 Pediatric Crohn'S Disease
1.4 United States Crohn?s Disease Drug Market by Region
  1.4.1 United States Crohn?s Disease Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Crohn?s Disease Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Crohn?s Disease Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Crohn?s Disease Drug Status and Prospect (2013-2025)
  1.4.5 New England Crohn?s Disease Drug Status and Prospect (2013-2025)
  1.4.6 The South Crohn?s Disease Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Crohn?s Disease Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Crohn?s Disease Drug (2013-2025)
  1.5.1 United States Crohn?s Disease Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Crohn?s Disease Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES CROHN?S DISEASE DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Crohn?s Disease Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Crohn?s Disease Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Crohn?s Disease Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Crohn?s Disease Drug Market Competitive Situation and Trends
  2.4.1 United States Crohn?s Disease Drug Market Concentration Rate
  2.4.2 United States Crohn?s Disease Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Crohn?s Disease Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CROHN?S DISEASE DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Crohn?s Disease Drug Sales and Market Share by Region (2013-2018)
3.2 United States Crohn?s Disease Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Crohn?s Disease Drug Price by Region (2013-2018)

4 UNITED STATES CROHN?S DISEASE DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Crohn?s Disease Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Crohn?s Disease Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Crohn?s Disease Drug Price by Type (2013-2018)
4.4 United States Crohn?s Disease Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES CROHN?S DISEASE DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Crohn?s Disease Drug Sales and Market Share by Application (2013-2018)
5.2 United States Crohn?s Disease Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES CROHN?S DISEASE DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AbbVie
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Crohn?s Disease Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Crohn?s Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Janssen Biotech
  6.2.2 Crohn?s Disease Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Janssen Biotech Crohn?s Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 UCB
  6.3.2 Crohn?s Disease Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 UCB Crohn?s Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Amgen
  6.4.2 Crohn?s Disease Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Amgen Crohn?s Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Tillotts Pharma
  6.5.2 Crohn?s Disease Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Tillotts Pharma Crohn?s Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Takeda Pharmaceuticals
  6.6.2 Crohn?s Disease Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Takeda Pharmaceuticals Crohn?s Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview

7 CROHN?S DISEASE DRUG MANUFACTURING COST ANALYSIS

7.1 Crohn?s Disease Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Crohn?s Disease Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Crohn?s Disease Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Crohn?s Disease Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CROHN?S DISEASE DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Crohn?s Disease Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Crohn?s Disease Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Crohn?s Disease Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Crohn?s Disease Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Crohn?s Disease Drug
Figure United States Crohn?s Disease Drug Market Size (K Units) by Type (2013-2025)
Figure United States Crohn?s Disease Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Aminosalicylates (5-ASA) Product Picture
Figure Corticosteroids Product Picture
Figure Immunomodulators Product Picture
Figure Antibiotics Product Picture
Figure United States Crohn?s Disease Drug Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Crohn?s Disease Drug by Application in 2017
Figure Achieving Remission (The Absence Of Symptoms) Examples
Table Key Downstream Customer in Achieving Remission (The Absence Of Symptoms)
Figure Maintaining Remission (Prevention Of Flare-Ups) Examples
Table Key Downstream Customer in Maintaining Remission (Prevention Of Flare-Ups)
Figure Pediatric Crohn'S Disease Examples
Table Key Downstream Customer in Pediatric Crohn'S Disease
Figure United States Crohn?s Disease Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Crohn?s Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Crohn?s Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Crohn?s Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Crohn?s Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Crohn?s Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Crohn?s Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Crohn?s Disease Drug Sales (K Units) and Growth Rate (2013-2025)
Figure United States Crohn?s Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Crohn?s Disease Drug Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Crohn?s Disease Drug Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Crohn?s Disease Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Crohn?s Disease Drug Sales Share by Players/Suppliers
Figure 2017 United States Crohn?s Disease Drug Sales Share by Players/Suppliers
Figure United States Crohn?s Disease Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Crohn?s Disease Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Crohn?s Disease Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Crohn?s Disease Drug Revenue Share by Players/Suppliers
Figure 2017 United States Crohn?s Disease Drug Revenue Share by Players/Suppliers
Table United States Market Crohn?s Disease Drug Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Crohn?s Disease Drug Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Crohn?s Disease Drug Market Share of Top 3 Players/Suppliers
Figure United States Crohn?s Disease Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Crohn?s Disease Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Crohn?s Disease Drug Product Category
Table United States Crohn?s Disease Drug Sales (K Units) by Region (2013-2018)
Table United States Crohn?s Disease Drug Sales Share by Region (2013-2018)
Figure United States Crohn?s Disease Drug Sales Share by Region (2013-2018)
Figure United States Crohn?s Disease Drug Sales Market Share by Region in 2017
Table United States Crohn?s Disease Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Crohn?s Disease Drug Revenue Share by Region (2013-2018)
Figure United States Crohn?s Disease Drug Revenue Market Share by Region (2013-2018)
Figure United States Crohn?s Disease Drug Revenue Market Share by Region in 2017
Table United States Crohn?s Disease Drug Price (USD/Unit) by Region (2013-2018)
Table United States Crohn?s Disease Drug Sales (K Units) by Type (2013-2018)
Table United States Crohn?s Disease Drug Sales Share by Type (2013-2018)
Figure United States Crohn?s Disease Drug Sales Share by Type (2013-2018)
Figure United States Crohn?s Disease Drug Sales Market Share by Type in 2017
Table United States Crohn?s Disease Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Crohn?s Disease Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Crohn?s Disease Drug by Type (2013-2018)
Figure Revenue Market Share of Crohn?s Disease Drug by Type in 2017
Table United States Crohn?s Disease Drug Price (USD/Unit) by Types (2013-2018)
Figure United States Crohn?s Disease Drug Sales Growth Rate by Type (2013-2018)
Table United States Crohn?s Disease Drug Sales (K Units) by Application (2013-2018)
Table United States Crohn?s Disease Drug Sales Market Share by Application (2013-2018)
Figure United States Crohn?s Disease Drug Sales Market Share by Application (2013-2018)
Figure United States Crohn?s Disease Drug Sales Market Share by Application in 2017
Table United States Crohn?s Disease Drug Sales Growth Rate by Application (2013-2018)
Figure United States Crohn?s Disease Drug Sales Growth Rate by Application (2013-2018)
Table AbbVie Basic Information List
Table AbbVie Crohn?s Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Crohn?s Disease Drug Sales Growth Rate (2013-2018)
Figure AbbVie Crohn?s Disease Drug Sales Market Share in United States (2013-2018)
Figure AbbVie Crohn?s Disease Drug Revenue Market Share in United States (2013-2018)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Crohn?s Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Janssen Biotech Crohn?s Disease Drug Sales Growth Rate (2013-2018)
Figure Janssen Biotech Crohn?s Disease Drug Sales Market Share in United States (2013-2018)
Figure Janssen Biotech Crohn?s Disease Drug Revenue Market Share in United States (2013-2018)
Table UCB Basic Information List
Table UCB Crohn?s Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure UCB Crohn?s Disease Drug Sales Growth Rate (2013-2018)
Figure UCB Crohn?s Disease Drug Sales Market Share in United States (2013-2018)
Figure UCB Crohn?s Disease Drug Revenue Market Share in United States (2013-2018)
Table Amgen Basic Information List
Table Amgen Crohn?s Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Crohn?s Disease Drug Sales Growth Rate (2013-2018)
Figure Amgen Crohn?s Disease Drug Sales Market Share in United States (2013-2018)
Figure Amgen Crohn?s Disease Drug Revenue Market Share in United States (2013-2018)
Table Tillotts Pharma Basic Information List
Table Tillotts Pharma Crohn?s Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Tillotts Pharma Crohn?s Disease Drug Sales Growth Rate (2013-2018)
Figure Tillotts Pharma Crohn?s Disease Drug Sales Market Share in United States (2013-2018)
Figure Tillotts Pharma Crohn?s Disease Drug Revenue Market Share in United States (2013-2018)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Crohn?s Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceuticals Crohn?s Disease Drug Sales Growth Rate (2013-2018)
Figure Takeda Pharmaceuticals Crohn?s Disease Drug Sales Market Share in United States (2013-2018)
Figure Takeda Pharmaceuticals Crohn?s Disease Drug Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Crohn?s Disease Drug
Figure Manufacturing Process Analysis of Crohn?s Disease Drug
Figure Crohn?s Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Crohn?s Disease Drug Major Players/Suppliers in 2017
Table Major Buyers of Crohn?s Disease Drug
Table Distributors/Traders List
Figure United States Crohn?s Disease Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Crohn?s Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Crohn?s Disease Drug Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Crohn?s Disease Drug Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Crohn?s Disease Drug Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Crohn?s Disease Drug Sales Volume (K Units) Forecast by Type in 2025
Table United States Crohn?s Disease Drug Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Crohn?s Disease Drug Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Crohn?s Disease Drug Sales Volume (K Units) Forecast by Application in 2025
Table United States Crohn?s Disease Drug Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Crohn?s Disease Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Crohn?s Disease Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Crohn?s Disease Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources